C4X Discovery announces selection of a once-daily development candidate from its α4β7 inhibitor programme

C4X Discovery Holdings PLC. C4X Discovery Holdings Ltd. C4X Discovery announces selection of a once-daily development ...
Investor's Business Daily on MSN

IBD Rating Upgrades: AtriCure Flashes Improved Price Strength

AtriCure holds the No. 7 rank among its peers in the Medical-Systems/Equipment industry group. Brainsway ADR BWAY, iRadimed ...
Investor's Business Daily on MSN

Kymera Therapeutics Sees IBD RS Rating Rise To 71

Over 100 years of market history reveals that the best-performing stocks tend to have an RS Rating of at least 80 as they ...
Rolling Out

Experts find 4 links between IBD and autoimmune conditions

Inflammatory bowel disease (IBD) belongs to a broader category of health conditions known as immune-mediated inflammatory diseases (IMIDs). These disorders share a common characteristic: chronic ...
Medscape

Patients With IBD More Likely to Develop, or Have Prior, T1D

VIENNA — Researchers have determined a bidirectional relationship between inflammatory bowel disease (IBD) and type 1 diabetes (T1D), using both a cohort and case-control approach to analysis. Their ...